Nutriflog tablets

22.90

  • Description

     

    Indications
    Nutriflog is a food supplement based on Turmeric and Boswellia that promote joint function and digestive system.
     

    The benefits of Nutriflog tablets
    Nutriflog tablets are designed to support the body in cases of acute and chronic inflammatory joint and intestinal states such as irritable bowel syndrome (IBS) and diverticulitis. The association of two patented and clinically tested liposomal extracts such as Cureit® and Casperome® ensures that the product has a bioavailability and a tested efficacy superior to the common extracts.
     

    Posology and duration of treatment
    We recommend taking 1-2 tablets a day to be swallowed with a little water, preferably after breakfast and after dinner.
     

    INGREDIENTS: CUREIT® (CURCUMA LONGA L.) RIZOMA E.S. TIT. AL 45% IN TOTAL CURCUMINOIDS, CASPEROME® (BOSWELLIA SERRATA ROXB EX COLEBR., SOYA LECITHIN) RESIN E.S. TIT. AL 25% IN TOTAL AND 10% THERAPY ACIDES IN TOTAL BETA-BOSWELLIC ACIDS, CHARGING AGENTS: MICROCRYSTALLINE CELLULOSE, DICALCICAL PHOSPHATE; ANTIAGGLOMERANTI AGENTS: CARBOSSIMETILCELLULOSA RETICULATED SODIUM, SILICON DIOXIDE, MAGNESIUM SALTS OF FATTY ACIDS. WITHOUT GLUTEN, LACTOSE AND GMO. 

    The raw material obtained from the rhizome of Curcuma longa contains the main active compounds responsible for the multiple biological effects of the plant: the curcuminoids that represent 50% of the extract are able to exert an anti-inflammatory, antioxidant, anti-microbial activity and hepatoprotective. Cureit® also contains turmeric oil with antiviral, antimicrobial and hepatoprotective action. Cureit® is supported by scientific evidence and has a bioavailability 10 times higher than standard Curcuma extracts, thanks to the Polar-Non-Polar-Sandwich (PNS) Technology extraction mode. 

    Modern Western research has highlighted in the resin of Boswellia a series of substances called boswellic acids, with a particular pharmacological activity: they are able to inhibit some enzymes such as 5-lipoxygenase, which participate in the synthesis of leukotrienes, involved in chronic inflammatory processes. Unlike common anti-inflammatory drugs, boswellic acids do not interfere with prostaglandin synthesis and have not been shown to have ulcerogenic effects.

    WARNINGS: follow the recommended daily dose. Food supplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle. It is advisable not to take during pregnancy and lactation. Do not use in case of confirmed sensitivity towards one of the components. The product must be kept out of reach of children under 3 years of age.